Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumovax™ 23 in Healthy Participants 50 Years of Age and Older (V110-029)
Clinical trial NCT02225587 · COMPLETED
Trial details
- NCT number
- NCT02225587
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-28
- Primary completion
- 2015-07-06
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.